MODULATION OF AIRWAY EPITHELIAL CYTOKINE RECEPTOR FUNCTION
气道上皮细胞因子受体功能的调节
基本信息
- 批准号:5201080
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Airway epithelial cells express receptors for the proinflammatory
cytokines TNF-alpha and IL-1beta. Cells may modulate cytokine responses by
the alteration of cellular receptor numbers or affinity. Airway epithelial
cells express the P55 TNFalpha receptor. Protein Kinase C activation by
phorbol ester in a human epithelial cell line or in human airway
epithelial cells in primary culture results in the solubilization of cell
surface P55 TNFalpha receptors. Similarly IL-1beta treatment of airway
epithelial cells induces the shedding of TNFalpha P55 receptors. This
effect is inhibited by pretreatment of the cells with the PKC antagonist
calphostin C. Conversely, dexamethasone treatment of epithelial cells
results in an increase in cell associated TNFalpha receptor protein and in
a reduction of TNFalpha receptor shedding. One manuscript has been
prepared and studies are in progress to investigate the mechanisms of PKC
induced TNFalpha receptor shedding as well as other mechanisms of
epithelial cell modulation of cytokine responses. A knowledge of the
mechanisms by which epithelial cells may modulate responses to
inflammatory cytokines may allow for new therapeutic approaches to the
reduction of airway inflammation.
气道上皮细胞表达促炎因子受体
细胞因子TNF-α和IL-1 β。细胞可以通过以下方式调节细胞因子应答:
细胞受体数量或亲和力的改变。气道上皮
细胞表达P55 TNF α受体。蛋白激酶C激活
人上皮细胞系或人气道中佛波酯
原代培养中的上皮细胞导致细胞溶解
表面P55 TNF α受体。类似地,气道IL-1 β治疗
上皮细胞诱导TNF α P55受体的脱落。这
用PKC拮抗剂预处理细胞可抑制这种作用
钙磷素C相反,地塞米松治疗上皮细胞
导致细胞相关TNF α受体蛋白的增加,
TNF α受体脱落减少。其中一份手稿
研究正在进行中,以研究PKC的机制。
诱导的TNF α受体脱落以及其他
上皮细胞调节细胞因子应答。的知识
上皮细胞可能调节对
炎性细胞因子可能允许新的治疗方法,
减轻气道炎症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
S LEVINE其他文献
S LEVINE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('S LEVINE', 18)}}的其他基金
NOVEL HUMAN BRONCHIAL EPITHELIAL CELL GENES INVOLVED IN AIRWAY INFLAMMATION
与气道炎症相关的新型人类支气管上皮细胞基因
- 批准号:
6161440 - 财政年份:
- 资助金额:
-- - 项目类别:
NOVEL HUMAN BRONCHIAL EPITHELIAL CELL GENES INVOLVED IN AIRWAY INFLAMMATION
与气道炎症相关的新型人类支气管上皮细胞基因
- 批准号:
6103583 - 财政年份:
- 资助金额:
-- - 项目类别:
MODULATION OF AIRWAY EPITHELIAL CELL CYTOKINE RECEPTOR FUNCTION
气道上皮细胞细胞因子受体功能的调节
- 批准号:
6103585 - 财政年份:
- 资助金额:
-- - 项目类别:
NOVEL HUMAN BRONCHIAL EPITHELIAL CELL GENES INVOLVED IN AIRWAY INFLAMMATION
与气道炎症相关的新型人类支气管上皮细胞基因
- 批准号:
2456668 - 财政年份:
- 资助金额:
-- - 项目类别:
WATER INTOXICATION, SCHIZOPHRENIA AND DIURETIC THERAPY FOR HYPERTENSION
水中毒、精神分裂症和高血压的利尿疗法
- 批准号:
4694663 - 财政年份:
- 资助金额:
-- - 项目类别:
MODULATION OF AIRWAY EPITHELIAL CELL CYTOKINE RECEPTOR FUNCTION
气道上皮细胞细胞因子受体功能的调节
- 批准号:
2456670 - 财政年份:
- 资助金额:
-- - 项目类别:
MODULATION OF AIRWAY EPITHELIAL CELL CYTOKINE RECEPTOR FUNCTION
气道上皮细胞细胞因子受体功能的调节
- 批准号:
6161442 - 财政年份:
- 资助金额:
-- - 项目类别:
INFLAMMATORY CYTOKINE MODULATION OF AIRWAY MUCIN PRODUCTION
气道粘蛋白产生的炎症细胞因子调节
- 批准号:
5201077 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Establishment of optimal equipment settings for dexamethasone inhalation therapy in very preterm infants.
建立极早产儿地塞米松吸入治疗的最佳设备设置。
- 批准号:
22K18171 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Dexamethasone to target stress and immune system changes during early abstinence in individuals with Alcohol Use Disorder (AUD)
地塞米松可针对酒精使用障碍 (AUD) 患者早期戒酒期间的压力和免疫系统变化
- 批准号:
10491302 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Study on the Significance of Dexamethasone in Lymphoid Malignancies
地塞米松在淋巴恶性肿瘤中的意义研究
- 批准号:
21K20848 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Research Activity Start-up
Dexamethasone to target stress and immune system changes during early abstinence in individuals with Alcohol Use Disorder (AUD)
地塞米松可针对酒精使用障碍 (AUD) 患者早期戒酒期间的压力和免疫系统变化
- 批准号:
10350207 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Optimizing Delivery of a Known Therapeutic Agent, Dexamethasone, to Improve Microelectrode Recording Performance
优化已知治疗剂地塞米松的输送,以提高微电极记录性能
- 批准号:
10418649 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Elucidation of the molecular mechanism of synergistic anti-myeloma effects of dexamethasone and IMiDs
阐明地塞米松和 IMiD 协同抗骨髓瘤作用的分子机制
- 批准号:
20K08741 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Optimizing Delivery of a Known Therapeutic Agent, Dexamethasone, to Improve Microelectrode Recording Performance
优化已知治疗剂地塞米松的输送,以提高微电极记录性能
- 批准号:
10642761 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Dexamethasone as an Effective Therapy for Ocular Injuries by Vesicating Agents.
地塞米松是治疗眼部损伤的有效疗法。
- 批准号:
10472580 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Dexamethasone as an Effective Therapy for Ocular Injuries by Vesicating Agents.
地塞米松是治疗眼部损伤的有效疗法。
- 批准号:
10220981 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Optimizing Delivery of a Known Therapeutic Agent, Dexamethasone, to Improve Microelectrode Recording Performance
优化已知治疗剂地塞米松的输送,以提高微电极记录性能
- 批准号:
10217285 - 财政年份:2020
- 资助金额:
-- - 项目类别: